Skin Moles and Keratinocytic Nevi: What You Need to Know
"A comprehensive guide to understanding epidermal nevi, their genetic origins, and associated syndromes."
Skin moles, clinically known as nevi, are common. Epidermal nevi, specifically, are benign, tumor-like malformations that originate from the epidermis and sometimes the skin's adnexal structures (like hair follicles and sweat glands). Historically, these nevi have been categorized by their appearance. However, recent genetic research has begun to shed light on their origins and links to other health conditions.
This article dives into the world of epidermal nevi, focusing on keratinocytic nevi. We'll explore how these skin lesions develop, what genetic factors are involved, and what associated syndromes you should be aware of. This is the first part of a series, focusing specifically on nevi derived from the epidermis.
Whether you're someone with a newfound interest in skin health, have noticed a mole that concerns you, or simply want to expand your knowledge, this guide offers accessible insights into the nature, genetics, and potential implications of keratinocytic nevi.
Why Moles Matter
Moles and keratinocytic nevi are common skin findings, but their significance varies. Many are benign, while some changes may warrant professional evaluation. Because appearance alone cannot always establish a diagnosis, persistent, changing, or unusual lesions should be assessed by a qualified clinician.
Evaluation and Removal
Clinical mole examinations focus on features that may increase suspicion of cancer, since a nevus can be normal or represent malignancy. Differentiating early melanoma from melanocytic nevi remains challenging because evidence-based non-invasive diagnostic and screening techniques are limited. Removal methods also have tradeoffs: the SF method aims to reduce visible scarring but cannot eliminate the risk of scar formation, especially on the face, while superficial removal may be limited to small, elevated moles, allow recurrence, and provide an inadequate specimen for histopathology.
Understanding the Nevus
The term nevus comes from the Latin word for birthmark, although nevi may be congenital or acquired. Epidermal nevi are understood as benign overgrowths involving the epidermis, the outermost layer of skin. Pathology descriptions identify them as developmental malformations that may appear as congenital linear patches or plaques along Blaschko lines, while newer accounts associate them with postzygotic variants in ectoderm-derived cell lines such as keratinocytes and adnexal cells.
What are Keratinocytic Nevi and How Do They Develop?
A hamartoma, the origin of skin nevi, is a benign, tumor-like malformation that arises due to an abnormal mixture of mature tissue elements. Unlike neoplasms, hamartomas don't involve autonomous, uncontrolled growth. When these occur in the skin, they're called nevi.
- Somatic mutations in autosomal dominant genes: These mutations, which would be lethal in a zygote, persist in a mosaic form, affecting only a group of cells that survive due to proximity to normal cells. These mutations often involve the PI3K and MAP-kinase pathways, crucial for cell survival and proliferation.
- Nonlethal mutations in autosomal genes: These mutations cause extensive skin disease when present in the zygote but can manifest in mosaic form following a postzygotic mutation. This can lead to exclusively mosaic involvement in otherwise healthy individuals (type 1 Happle mosaicism) or occur in patients already presenting a generalized form of the disease (type 2 mosaicism).
- Mosaic mutations or epigenetic changes: These occur in genes linked to polygenic inflammatory diseases.
- Functional mosaicism: This is linked to random X chromosome inactivation in women, also known as lyonization.
Genetics and Emerging Research
The 2025 review by Gianluca Tadini and Michela Brena describes epidermal nevi as arising from postzygotic variants in ectoderm-derived cell lines, including keratinocytes and cells forming adnexa. These lesions may occur alone or as part of an epidermal naevus syndrome. Current research also examines mosaicism, neoplastic outcomes, and reported cases of linear epidermal nevi with epidermolytic hyperkeratosis, including their implications for transmission of epidermolytic ichthyosis.
Limits of a Single Explanation
Epidermal nevi are not a single uniform condition: reported forms include linear, epidermolytic, acantholytic, linear porokeratosis, and systematised epidermal nevi. DermNet reports that lesions are present at birth in about 50% of cases or develop during childhood, mostly during the first year, and result from an overgrowth of keratinocytes. When epidermal nevi occur with abnormalities in other organs, particularly the brain, eyes, or musculoskeletal system, they may form part of an epidermal naevus syndrome rather than an isolated skin finding.
Different Types of Moles
Common moles, dysplastic nevi, and melanoma can differ in size, color, shape, and surface texture. Junctional nevi are named for the location of their melanocytes at the junction of the epidermis and dermis, and they may occur on the face, arms, legs, trunk, genitals, or soles of the feet. Junctional, compound, and intradermal nevi are distinct categories that may require dermatologic assessment when their appearance or behavior is concerning.
Key Takeaways and Next Steps in Understanding Keratinocytic Nevi
Keratinocytic nevi are complex skin lesions arising from genetic mosaicism during development. While typically benign, understanding their genetic basis and potential associations with syndromes is crucial.
Putting the Findings Together
Moles and keratinocytic nevi encompass a broad range of benign-appearing lesions with different cellular origins and clinical patterns. Their evaluation requires attention to the lesion's appearance, history, and any associated findings. Because some lesions can resemble more serious conditions, professional assessment remains important when uncertainty or change is present.
Where Research Is Heading
Future work may improve how clinicians distinguish benign nevi from lesions requiring further investigation. Research into genetic mosaicism, targeted therapies, and non-invasive assessment could contribute to more individualized care. The pace and clinical impact of these developments remain uncertain.
Challenges in Care
A central challenge is balancing reassurance for benign lesions with timely recognition of potentially serious disease. Variation in lesion type, appearance, and associated abnormalities can complicate evaluation. Clear clinical assessment and appropriate follow-up are therefore important parts of care.
Living With Nevi
Nevi may be congenital or develop later in life, and they are generally considered benign, although nevus cells are histologically distinct from ordinary melanocytes. The same oncogenic driver mutations can be found in benign nevi and melanoma, underscoring why diagnosis cannot rely on a single molecular feature alone. A 2025 case report describes verrucous epidermal nevus as a benign congenital hamartoma caused by abnormal keratinocyte proliferation, while MyPath Melanoma case studies illustrate the use of testing to support diagnostic and treatment decisions.
If you notice a new or changing mole, particularly one that follows a linear pattern or is associated with other unusual symptoms, consult a dermatologist. Genetic testing and careful clinical evaluation can help determine the nature of the lesion and any associated risks.
This article serves as a starting point. As research progresses, our understanding of epidermal nevi and their genetic underpinnings will continue to evolve, leading to improved diagnostics and management strategies. Stay informed and proactive about your skin health.